4D Molecular Therapeutics
FDMT
FDMT
145 hedge funds and large institutions have $262M invested in 4D Molecular Therapeutics in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 50 increasing their positions, 46 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10.73% less ownership
Funds ownership: 112.06% → 101.33% (-11%)
58% less capital invested
Capital invested by funds: $630M → $262M (-$369M)
Holders
145
Holding in Top 10
–
Calls
$858K
Puts
$370K
Top Buyers
| 1 | +$10.5M | |
| 2 | +$5.37M | |
| 3 | +$3.96M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.75M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$3.36M |
Top Sellers
| 1 | -$37M | |
| 2 | -$27.4M | |
| 3 | -$11.4M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$9.06M |
| 5 |
State Street
Boston,
Massachusetts
|
-$7.88M |